Analyst Ratings for Medpace (MEDP)
MEDP Rating Summary
MEDP Price Target Summary
- Highest: $582.00 (Mizuho)
- Lowest: $305.00 (UBS)
- Average: $491.82
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$491.82 (+4.5%)
* Over Last 12-Mos
Rating Score: 3 / 10
Percentile Rank: 26%
Avg. $ Target:
$491.82 (+4.5%)
* Over Last 12-Mos
Rating Score: 3 / 10
Percentile Rank: 26%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/6/2026 | Barclays | Luke Sergott | Upgrade | Equalweight (Underweight) |
500.00 (N/A) |
469.38 (470.59) |
0.26% | Details |
| 3/3/2026 | RBC Capital | Ryan Halsted | New Coverage | Outperform (N/A) |
522.00 (N/A) |
451.76 (470.59) |
4.17% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
